Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity

scientific article

Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PNTD.0004497
P932PMC publication ID4794248
P698PubMed publication ID26982706
P5875ResearchGate publication ID298729706

P50authorTavpritesh SethiQ56883880
Guruprasad MedigeshiQ42617334
P2093author name stringRakesh Lodha
Sushil K Kabra
Mohit Singla
Anmol Chandele
Meenakshi Kar
P2860cites workPlatelet-derived CD40L: the switch-hitting player of cardiovascular diseaseQ74627856
Elevated levels of IL-8 in dengue hemorrhagic feverQ77448556
Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosisQ77768132
Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival ForestsQ22673963
Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reactionQ24291041
The global distribution and burden of dengueQ24628768
Virus Replication and Cytokine Production in Dengue Virus-Infected Human B LymphocytesQ27472941
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severityQ27486434
Interleukin-10 determines viral clearance or persistence in vivoQ27486832
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue feverQ27486912
A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever ModelQ27490166
Clinical Findings and Pro-Inflammatory Cytokines in Dengue Patients in Western India: A Facility-Based StudyQ27490805
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severityQ27860703
Cytokine patterns during dengue shock syndrome.Q31031005
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infectionsQ33342343
Dengue hemorrhagic fever in infants: a study of clinical and cytokine profilesQ33358547
Serotype-specific differences in clinical manifestations of dengueQ33370483
Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspasesQ33406043
Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized miceQ33409934
Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in MalaysiaQ33414050
Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patientsQ33785818
Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam.Q33841915
Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesisQ33949186
Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiationQ33976500
Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replicationQ34634755
Economic and disease burden of dengue illness in IndiaQ34640305
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexesQ34671059
Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infectionQ34754885
Serum IL-10 as a marker of severe dengue infectionQ34862804
Suppression of virus specific immune responses by IL-10 in acute dengue infectionQ34990697
Infection of bone marrow cells by dengue virus in vivoQ36152427
Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such primingQ36638672
Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).Q36666340
Adaptor protein complexes-1 and 3 are involved at distinct stages of flavivirus life-cycleQ36828955
IL-10: the master regulator of immunity to infectionQ37143028
Robustness of Random Forest-based gene selection methods.Q37501154
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine stormsQ37901360
IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasisQ38007051
Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse modelsQ38498172
Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective studyQ38874657
The association of cytokines with severe dengue in childrenQ39210623
Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper MyanmarQ39302764
Immunopathogenesis of dengue hemorrhagic fever: contribution to the study of human liver lesionsQ39333506
IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in CubaQ39372304
Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever.Q40469577
Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.Q40470307
Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1.Q40478465
Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic feverQ40512486
IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers.Q40531128
Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in ThailandQ40539101
High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesisQ40565852
Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reactionQ40610338
Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French PolynesiaQ40626033
Elevated plasma interleukin-10 levels in acute dengue correlate with disease severityQ40632182
Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections.Q40638126
Downregulation of interferon-β in antibody-dependent enhancement of dengue viral infections of human macrophages is dependent on interleukin-6.Q43038468
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectIndiaQ668
Dengue virusQ476209
P304page(s)e0004497
P577publication date2016-03-16
P1433published inPLoS Neglected Tropical DiseasesQ3359737
P1476titleImmune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity
P478volume10

Reverse relations

cites work (P2860)
Q90560585A review of Dengvaxia®: development to deployment
Q91212064Adaptive immune responses to primary and secondary dengue virus infections
Q40064311Antiviral and Immunomodulatory Effects of Norantea brasiliensis Choisy on Dengue Virus-2.
Q37448371Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India
Q42882047Correction: Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India-Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity
Q36085940Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials
Q33441760Dengue Virus Entry and Replication Does Not Lead to Productive Infection in Platelets
Q92294377Epidemiological characteristics of bacillary dysentery from 2009 to 2016 and its incidence prediction model based on meteorological factors
Q43047038Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas
Q95819383Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections
Q89967322Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes
Q58741516Immunization with a suicidal DNA vaccine expressing the E glycoprotein protects ducklings against duck Tembusu virus
Q90353798Isolation and molecular characterization of dengue virus clinical isolates from pediatric patients in New Delhi
Q36166556Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
Q36305184Mathematical modelling and a systems science approach to describe the role of cytokines in the evolution of severe dengue
Q41722923Meta-analysis of biomarkers for severe dengue infections.
Q91725883Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity
Q54208727Mosquito saliva alone has profound effects on the human immune system.
Q36116232N-Desmethylclozapine, Fluoxetine, and Salmeterol Inhibit Postentry Stages of the Dengue Virus Life Cycle
Q28119679Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection
Q54988577Simulation Model for Dynamics of Dengue with Innate and Humoral Immune Responses.
Q39139037The role of the unfolded protein response in dengue virus pathogenesis.

Search more.